Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A8673 LRGILS-NH2Summary: Protease-activated receptor agonist -
A8675 TRAP-6Target: PARSummary: PAR1 agonist -
A8676 2-Furoyl-LIGRLO-amideSummary: Protease-activated receptor agonist -
A8677 SLIGKV-NH2Summary: PAR2 agonist -
B1408 CNX-774Summary: BTK inhibitor, orally active, irreversible and selective -
B3242 PCI-32765 RacemateSummary: BTK inhibitor -
B3243 Btk inhibitor 1 R enantiomerSummary: Btk kinase inhibitor -
C6371 Calcium dobesilate -
B6106 Daprodustat(GSK1278863)Summary: HIF-prolyl hydroxylase inhibitor -
B6185 ACP-196Target: BTKSummary: irreversible BTK inhibitor
